The retail SH do not have direct impact on drug development - it is management that controls everything.
Mgmt can blame themselves for not being able manage their business environment, not getting right funding to start trials on time, not being anle to find partners to move faster, fda for not moving fast enough.
There are enough retail investors in market and if mgmt doing ok they will support. S